Clinical Trials Browser

Stomach Neoplasms

Cholangiocarcinoma

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

Locally Advanced Gastric Cancer

DMMR Colorectal Cancer

Rectal Neoplasms, Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Colonic Neoplasms

Cholangiocarcinoma

Carcinoma, Hepatocellular

Esophageal Neoplasms, Stomach Neoplasms

Pancreatic Adenocarcinoma

Lymphatic Metastasis, Colorectal Neoplasms

COVID-19, Colonic Neoplasms, Disease, Colorectal Neoplasms

Stomach Neoplasms

Carcinoma, Hepatocellular

Pancreatic Neoplasms

Stomach Neoplasms

Colonic Neoplasms, Recurrence

Rectal Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Stomach Neoplasms

Tissue Adhesions, Colorectal Neoplasms

Biliary Tract Neoplasms, Neoplasms

Rectal Neoplasms

Gastrointestinal Stromal Tumors

Carcinoma, Hepatocellular, Liver Neoplasms

Therapeutic Value of Endoscopic and Laparoscopic Resection for Small Gastric Gastrointestinal Stromal Tumor

Esophageal Neoplasms

Stomach Neoplasms

Esophageal Cancer TNM Staging Primary Tumor (T) T3

Stomach Neoplasms

Peritoneal Neoplasms, Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Esophageal Neoplasms

Gastrointestinal Stromal Tumors

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

Colonic Neoplasms

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

Rectal Neoplasms

Rectal Neoplasms

Advanced Gastric Cancer With Serosal Invasion

Cholangiocarcinoma

Esophageal Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Carcinoma, Hepatocellular

Stomach Neoplasms

Clinical Trials

The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric Cancer

Prognostic Factors for Survival in Patients With Cholangiocarcinoma

PITHAC

Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy

Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)

Locally Advanced Colorectal Cancer and Local Recurrences in Västra Götaland

GOETH

Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study

Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk

Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning

SOEGAS

Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer

EpiT1

COVID-CRC

A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer

Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular Carcinoma

FOLFIRINOX + RT for Pancreatic Cancer

HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis

Postoperative VEGF and Recurrence After Colon Cancer Surgery

CRONOS

NeoconceptC

NeoconceptB

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

Does Icodextrin Reduce the Risk of Small Bowel Obstruction?

The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer

Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy

Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment

Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma

CELSGIST

An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer

RECOMMEND

Detection of Circulating Tumor Tells as The Guidance of the Neoadjuvant Chemotherapy of Esophageal Cancer

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery

Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer

Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer

Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Metabolomic Phenotyping After Surgery for Colon Cancer: Study of Novel Predictive Biomarkers

HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis

Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer

BISER

EPIC-GC

VEGF ECC

NeoSCOPE

icc

HCC

D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer